1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ARAP3 CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA OTUD5 CTRPv2 pan-cancer AAC -0.17 3e-06
mRNA MGST2 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA KIR3DL1 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA SKA1 CTRPv2 pan-cancer AAC -0.18 4e-06
mRNA MYL10 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA RXRG CTRPv2 pan-cancer AAC 0.19 4e-06
mRNA RP11-307N16.6 CTRPv2 pan-cancer AAC 0.18 4e-06
mRNA CMTM7 CTRPv2 pan-cancer AAC 0.17 4e-06
mRNA KRT20 CTRPv2 pan-cancer AAC 0.18 4e-06
Download CSV